COBRE-DIABETES
COBRE-DIABETES
批准号:
10399857
负责人:
MARIANA GERSCHENSON
金额:
$23.18万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-01 至 2023-07-31
关键词:
AcuteAddressAdministrative SupplementAnimalsBioluminescenceBloodBlood VolumeBlood gasCenters of Research ExcellenceChemistryClinicalContract ServicesCore FacilityDiabetes MellitusDiagnosisDoseElectrolytesEquipmentEvaluationFluorescenceFosteringFundingFunding OpportunitiesGoalsGrowthHawaiiHematocrit procedureHemoglobinIndividualInfrastructureInvestigationLongitudinal StudiesMetabolicMinority GroupsModernizationMusNational Institute of General Medical SciencesPhasePopulationPreventionRenal functionResearchResearch PersonnelResourcesRoentgen RaysServicesSystemTechnologyTestingUniversitiesVisioncareer developmentcostequipment acquisitionhealth disparityimaging systemimprovedin vivoin vivo imaging systemmedical schoolsoperationrapid testresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
This application is for a supplement to support a Phase I Center of Biomedical Research Excellence (COBRE)
at the University of Hawaii (UH) on Diabetes (1P20GM113134-04) in response to funding opportunity NOT-
GM-21-029, “Administrative Supplements for Equipment Purchases for NIGMS-funded Center and Core
Facilities”. The COBRE-Diabetes has developed a Resource Core dedicated to supporting career development
for young investigators and to foster diabetes-related research in the state, which is acutely needed. It is
estimated that a third of the State’s population will be living with diabetes by the year 2050.
The COBRE-Diabetes Resource Core goal is to establish a new and easily accessible modern infrastructure to
support investigations in the mechanisms, diagnosis, prevention, and/or treatment of diabetes to address
health disparities in the minority populations in Hawaii. Our unique aim is to Maintain the growth and
enhance the sustainability of Resource Core. With this proposal, we will optimize our core capacity in order
to continue capacity improvement that has been successfully initiated in the first Phase of COBRE-Diabetes
funding. In order to accomplish this objective, we request funding for the acquisition of two new pieces of
equipment. We hope to replace an existing obsolete Xenogen Vivo Vision IVIS Lumina Imaging system with an
IVIS Lumina XRMS in vivo imaging system. This is equipment offers cutting edge in vivo fluorescence and
bioluminescence technology combined with low dose 2D X-ray allowing for non-invasive and precise metabolic
analyses. This will give us an expanded capacity with multiple animals to perform longitudinal studies. The
second equipment is an i-STAT clinical blood analyzer that operates with the advanced technology of single-
use i-STAT test cartridges offering a wide array of tests on a single platform, including rapid tests for
electrolytes, chemistries, blood gases, hematocrit and hemoglobin or the fast evaluation of metabolic status
and renal function. This system uses minimal blood volumes, which will not require animal (mouse) sacrifice.
Blood analyses are currently done using individual and dedicated kits that is laborious or contracting services
outside of the University. There are many projects ongoing in the DRC that can best be performed in Hawaii.
Our distance from US mainland requires that we develop a fundamental repertoire of Core services for
diabetes research with COBRE resources. The Dean of the Medical School has committed to provide
institutional support to cover the cost of operation for three years after the purchase of these equipment.
期刊论文(38)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.3390/cells11091399
发表时间:
2022-04-20
期刊:
CELLS
影响因子:
6
作者:
[Komai, Kyoko, Kawasaki, Nicholas K., Higa, Jason K., Matsui, Takashi]
通讯作者:
Matsui, Takashi
Bicuspid and unicuspid aortic valves: Different phenotypes of the same disease? Insight from the GenTAC Registry.
二叶式和单叶式主动脉瓣:同一疾病的不同表型?
DOI:
10.1111/chd.12520
发表时间:
2017
期刊:
Congenital heart disease
影响因子:
0.3
作者:
[Krepp,JosephM, Roman,MaryJ, Devereux,RichardB, Bruce,Adrienne, Prakash,SiddharthK, Morris,ShaineA, Milewicz,DiannaM, Holmes,KathrynW, Ravekes,William, Shohet,RalphV, Pyeritz,ReedE, Maslen,CherylL, Kroner,BarbaraL, Eagle,KimA, Pre]
通讯作者:
Pre
DOI:
10.1371/journal.pone.0261563
发表时间:
2021
期刊:
PloS one
影响因子:
3.7
作者:
[Gojanovich GS, Jacobson DL, Broadwell C, Karalius B, Kirmse B, Geffner ME, Jao J, Van Dyke RB, McFarland EJ, Silio M, Crain M, Gerschenson M, Pediatric HIV/AIDS Cohort Study]
通讯作者:
Pediatric HIV/AIDS Cohort Study
The effects of Tel2 on cardiomyocyte survival.
Tel2 对心肌细胞存活的影响。
DOI:
10.1016/j.lfs.2019.116665
发表时间:
2019
期刊:
Life sciences
影响因子:
6.1
作者:
[Yorichika,Naaiko, Baba,Yuichi, Shimada,BrianaK, Thakore,Manoj, Wong,SharonM, Kobayashi,Motoi, Higa,JasonK, Matsui,Takashi]
通讯作者:
Matsui,Takashi
DOI:
10.1111/bpa.12620
发表时间:
2018-11
期刊:
Brain pathology (Zurich, Switzerland)
影响因子:
--
作者:
[De Vilder EYG, Cardoen S, Hosen MJ, Le Saux O, De Zaeytijd J, Leroy BP, De Reuck J, Coucke PJ, De Paepe A, Hemelsoet D, Vanakker OM]
通讯作者:
Vanakker OM
共 19 条
MARC at University of Hawaii at Manoa
-
批准号:10624858
-
项目类别:
-
资助金额:$45.95万
-
财政年份:2021
-
负责人:MARIANA GERSCHENSON
-
依托单位:
COBRE-DIABETES
-
批准号:10387025
-
项目类别:
-
资助金额:$21.85万
-
财政年份:2017
-
负责人:MARIANA GERSCHENSON
-
依托单位:
Administrative and Mentoring Core
-
批准号:10013266
-
项目类别:
-
资助金额:$72.66万
-
财政年份:2017
-
负责人:MARIANA GERSCHENSON
-
依托单位:
COBRE-DIABETES
-
批准号:9211064
-
项目类别:
-
资助金额:$230.03万
-
财政年份:2017
-
负责人:MARIANA GERSCHENSON
-
依托单位:
COBRE-DIABETES
-
批准号:10395384
-
项目类别:
-
资助金额:$31.1万
-
财政年份:2017
-
负责人:MARIANA GERSCHENSON
-
依托单位:
COBRE-DIABETES
-
批准号:10013264
-
项目类别:
-
资助金额:$215.68万
-
财政年份:2017
-
负责人:MARIANA GERSCHENSON
-
依托单位:
Administrative and Mentoring Core
-
批准号:10252771
-
项目类别:
-
资助金额:$67.93万
-
财政年份:2017
-
负责人:MARIANA GERSCHENSON
-
依托单位:
COBRE-DIABETES
-
批准号:10252770
-
项目类别:
-
资助金额:$212.34万
-
财政年份:2017
-
负责人:MARIANA GERSCHENSON
-
依托单位:
HAWAII AIDS CLINICAL RESEARCH PROGRAM/MEDICINE
-
批准号:8168067
-
项目类别:
-
资助金额:$32.36万
-
财政年份:2010
-
负责人:MARIANA GERSCHENSON
-
依托单位:
Mitochondrial Determinants of Metabolic Disease in HIV-Infected Children
-
批准号:8150961
-
项目类别:
-
资助金额:$50.92万
-
财政年份:2010
-
负责人:MARIANA GERSCHENSON
-
依托单位:
Mitochondrial Determinants of Metabolic Disease in HIV-Infected Children
-
批准号:8680049
-
项目类别:
-
资助金额:$45.26万
-
财政年份:2010
-
负责人:MARIANA GERSCHENSON
-
依托单位:
Mitochondrial Determinants of Metabolic Disease in HIV-Infected Children
-
批准号:8088909
-
项目类别:
-
资助金额:$57.16万
-
财政年份:2010
-
负责人:MARIANA GERSCHENSON
-
依托单位:
Mitochondrial Determinants of Metabolic Disease in HIV-Infected Children
-
批准号:8289335
-
项目类别:
-
资助金额:$48.64万
-
财政年份:2010
-
负责人:MARIANA GERSCHENSON
-
依托单位:
Mitochondrial Determinants of Metabolic Disease in HIV-Infected Children
-
批准号:8473920
-
项目类别:
-
资助金额:$44.48万
-
财政年份:2010
-
负责人:MARIANA GERSCHENSON
-
依托单位:
MITOCHODRIAL DYSFUNCTION IN OBESITY AND DIABETES IN BLOOD
-
批准号:7858531
-
项目类别:
-
资助金额:$18.64万
-
财政年份:2009
-
负责人:MARIANA GERSCHENSON
-
依托单位:
Global HIV Drug Therapies and Mitochondrial Complications and Mechanisms
-
批准号:7758370
-
项目类别:
-
资助金额:$64.7万
-
财政年份:2008
-
负责人:MARIANA GERSCHENSON
-
依托单位:
Global HIV Drug Therapies and Mitochondrial Complications and Mechanisms
-
批准号:8213520
-
项目类别:
-
资助金额:$61.34万
-
财政年份:2008
-
负责人:MARIANA GERSCHENSON
-
依托单位:
HAWAII AIDS CLINICAL RESEARCH PROGRAM/MEDICINE
-
批准号:7725232
-
项目类别:
-
资助金额:$17.45万
-
财政年份:2008
-
负责人:MARIANA GERSCHENSON
-
依托单位:
Global HIV Drug Therapies and Mitochondrial Complications and Mechanisms
-
批准号:8013497
-
项目类别:
-
资助金额:$62.12万
-
财政年份:2008
-
负责人:MARIANA GERSCHENSON
-
依托单位:
Global HIV Drug Therapies and Mitochondrial Complications and Mechanisms
-
批准号:7425133
-
项目类别:
-
资助金额:$66.28万
-
财政年份:2008
-
负责人:MARIANA GERSCHENSON
-
依托单位:
海外基金